Roflumilast Cream Effective for AD in Phase 3 Studies

Treatment with roflumilast cream 0.15% once daily improved mild to moderate AD in two phase 3 randomized clinical trials of children 6 years or older and adults.
Medscape Medical News

source https://www.medscape.com/viewarticle/roflumilast-cream-0-15-improves-atopic-dermatitis-symptoms-2024a1000h1d?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?